1-4 of 4
Ludmila Demitrovicova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASP210 - a Potent Oligonucleotide-Based Inhibitor for Combating Both BCR-ABL1 Dependent and Independent TKI-Resistant CML Cells

Veronika Nemethova, Petra Mazancova, Boglarka Nemethova, Lucia Uhelska, Andrea Babelova, Michal Selc, Kristina Jakic, Ondrej Mitrovsky, Denisa Myslivcova, Marketa Zackova, Alexandra Poturnayova, Angelika Batorova, Antonia Hatalova, Katarina Slezakova, Lubos Drgona, Iveta Oravcova, Eva Mikuskova, Ludmila Demitrovicova, Andrej Vranovsky, Filip Razga
Journal: Blood
Blood (2022) 140 (Supplement 1): 12995–12996.
https://doi.org/10.1182/blood-2022-166148
Published: 2022
Journal Articles

Treatment Outcomes in Patients Treated with Tyrosine Kinase Inhibitors in "Slovak Registry of Chronic Myeloid Leukemia" (CAMELIA SK)

Zuzana Sninska, MD PhD, Martin Mistrik, MD PhD, Ass. Prof., Katarina Slezakova, MD PhD, Ludmila Demitrovicova, MD, Eva Mikuskova, MD PhD, Imrich Markuljak, MD, Juraj Chudej, MD PhD, Natalia Stecova, MD, Elena Tothova, Prof, MD PhD, Adriana Kafkova, MD PhD, Stanislav Palasthy, MD, Jana Lesko-Andrascikova, MD, Tereza Necasova, Bc, Eva Koritakova, RNDr
Journal: Blood
Blood (2016) 128 (22): 3087.
https://doi.org/10.1182/blood.V128.22.3087.3087
Published: 2016
Journal Articles

Treatment of Consecutive Patients with Chronic Myeloid Leukemia In the Cooperating Centers From the Slovak Republic After 2000 – A Report From the Population Based CAMELIA Registry

Eva Demeckova, Martin Mistrik, MD, PhD, Ludmila Demitrovicova, Juraj Chudej, MD, Imrich Markuliak, Elena Tothova, Jan Muzik, MSci, PhD, Ladislav Dusek
Journal: Blood
Blood (2011) 118 (21): 4439.
https://doi.org/10.1182/blood.V118.21.4439.4439
Published: 2011
Journal Articles

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses – Population Based Analysis of 458 Patients Treated Between 2003–2009.

Hana Klamova, Daniela Zackova, Edgar Faber, MD, PhD, Katerina Steinerova, Michal Karas, Eva Demeckova, Jaroslava Voglova, MD, Ludmila Demitrovicova, Elena Tothova, Juraj Chudej, MD, Imrich Markuljak, Tomas Kozak, Eduard Cmunt, M.D., Ph.D., Marie Jarosova, Katerina Machova-Polakova, Kyra Michalova, PhD, DSc, Ladislav Dusek, Jan Muzik, Martin Mistrik, Jiri Mayer, MD, PhD, Marek Trneny, MD, PhD, Karel Indrak, MD., PhD.
Journal: Blood
Blood (2010) 116 (21): 1239.
https://doi.org/10.1182/blood.V116.21.1239.1239
Published: 2010